Core Scientific, Inc.
CORZQ
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 41.67% | 43.44% | -482.03% | 207.66% | -375.61% |
| Total Depreciation and Amortization | -1.97% | -5.46% | 5.69% | -3.80% | 26.46% |
| Total Amortization of Deferred Charges | 12.69% | 166.02% | -29.55% | -12.23% | -- |
| Total Other Non-Cash Items | 52.79% | -47.70% | 297.26% | -215.81% | 548.07% |
| Change in Net Operating Assets | -561.28% | -15.92% | -40.76% | 212.54% | -231.73% |
| Cash from Operations | 141.64% | 374.50% | -94.57% | 2.17% | 299.39% |
| Capital Expenditure | 7.75% | -894.39% | 90.17% | -173.89% | -324.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.39% | -34.69% | 35.53% | -1,185.71% | 105.56% |
| Cash from Investing | 7.82% | -881.16% | 90.04% | -1,454.66% | 182.29% |
| Total Debt Issued | 36.31% | -- | -- | -- | -- |
| Total Debt Repaid | 94.84% | -1,599.46% | 9.84% | 5.69% | -18.94% |
| Issuance of Common Stock | 92.24% | 321.25% | -99.33% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 47.96% | -- | -100.00% | -- | -- |
| Cash from Financing | 228.26% | 1,299.55% | -127.94% | 397.11% | -18.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 272.17% | 1,012.57% | -138.53% | 672.93% | 144.99% |
